The tyrosine kinase inhibitor Bosutinib does not inhibit angiotensin II-induced abdominal aortic aneurysm: Validation of the importance of PDGFR and c-Kit tyrosine kinases by Imatinib. (January 2022)

Record Type:: Journal Article
Title:: The tyrosine kinase inhibitor Bosutinib does not inhibit angiotensin II-induced abdominal aortic aneurysm: Validation of the importance of PDGFR and c-Kit tyrosine kinases by Imatinib. (January 2022)
Main Title:: The tyrosine kinase inhibitor Bosutinib does not inhibit angiotensin II-induced abdominal aortic aneurysm: Validation of the importance of PDGFR and c-Kit tyrosine kinases by Imatinib
Authors:: Balboa Ramilo, Amanda
Becirovic-Agic, Mediha
Petri, Marcelo Heron
Mani, Kevin
Wanhainen, Anders
Wågsäter, Dick
Abstract:
Is Part Of:: Atherosclerosis. Volume 340(2022)
Journal:: Atherosclerosis
Issue:: Volume 340(2022)
Issue Display:: Volume 340, Issue 2022 (2022)
Year:: 2022
Volume:: 340
Issue:: 2022
Issue Sort Value:: 2022-0340-2022-0000
Page Start:: 68
Page End:: 69
Publication Date:: 2022-01
Subjects:: Aneurysm -- Tyrosine kinase -- Inhibitor -- Rupture
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2021.12.001 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 20306.xml